Alzheimer's disease: Current treatment options and future developments; Focus on rivaroxaban: a novel oral factor Xa inhibitor to prevent stroke in nonvalvular atrial fibrillation

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Formulary Digital Edition July 2011

Newsletter